Hyperglycemia decreases the production of type I IFN, while low intracellular GSH concentrations reduce IL-12 and IFN-γ production, leaving patients vulnerable to multiple pathogens (34, 35). The gene discussed is IFNG; the disease is Hyperglycemia.